title: FDA moves closer to new requirements for NTI drugs.
authors.forename: Kate
authors.initials: K
authors.lastname: Traynor
mesh_terms: D004335:Drug and Narcotic Control; D064420:Drug-Related Side Effects and Adverse Reactions; D016568:Drugs, Generic / Q000009:adverse effects / Q000493:pharmacokinetics*; D006801:Humans; D004364:Pharmaceutical Preparations / Q000008:administration & dosage* / Q000378:metabolism; D013810:Therapeutic Equivalency; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D016568:Drugs, Generic; D004364:Pharmaceutical Preparations